APA (7th ed.) Citation

A, H., A, B., B, T., S, I., F, G., MR, A., . . . A, M. S. (2023). The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy. Frontiers in immunology, 14, 1127358. https://doi.org/10.3389/fimmu.2023.1127358

Chicago Style (17th ed.) Citation

A, Hasankhani, Bahrami A, Tavakoli-Far B, Iranshahi S, Ghaemi F, Akbarizadeh MR, Amin AH, Abedi Kiasari B, and Mohammadzadeh Shabestari A. "The Role of Peroxisome Proliferator-activated Receptors in the Modulation of Hyperinflammation Induced by SARS-CoV-2 Infection: A Perspective for COVID-19 Therapy." Frontiers in Immunology 14 (2023): 1127358. https://doi.org/10.3389/fimmu.2023.1127358.

MLA (9th ed.) Citation

A, Hasankhani, et al. "The Role of Peroxisome Proliferator-activated Receptors in the Modulation of Hyperinflammation Induced by SARS-CoV-2 Infection: A Perspective for COVID-19 Therapy." Frontiers in Immunology, vol. 14, 2023, p. 1127358, https://doi.org/10.3389/fimmu.2023.1127358.